REVB News and Press, Revelation Biosciences Inc.

2024-05-10 16:58:19 ET More on Revelation Biosciences Revelation Biosciences GAAP EPS of -$8.33 Seeking Alpha’s Quant Rating on Revelation Biosciences Historical earnings data for Revelation Biosciences Financial information for Revelation Biosciences ...

Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, today reported its three months ended March 31, ...

2024-03-22 16:20:06 ET More on Revelation Biosciences Revelation Biosciences to raise ~$6.2M through public offering of shares Seeking Alpha’s Quant Rating on Revelation Biosciences Historical earnings data for Revelation Biosciences Financial informat...

Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, today reported its three and twelve months ended...

2024-03-13 10:00:21 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Waters, Moderna most shorted ...

– Prophylactic administration of Gemini (Intravenous PHAD®) reduces tissue damage and improves kidney function in a rat model of bilateral ischemic reperfusion induced acute kidney injury (AKI) - Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or ...

Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation) a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, announced today that its Chief Executive Officer James Rol...

2024-03-11 09:30:53 ET Kidpik  ( PIK ) +281% . L.S. Starrett ( SCX ) +59% Enters Into a Merger Agreement With MiddleGround Capital to Become Private Company. TC BioPharm  ( TCBP ) +57% . Unusual Machines  ( UMAC ) +34% . A...

-Top-line data including safety, tolerability, and biomarker activity anticipated this summer- -This Phase 1 clinical study data will support further development across multiple indications- Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revel...

2024-02-21 08:22:42 ET Gainers: Sound Group  ( SOGP ) +113% Embraces Generative AI to Unveil New AI-Powered Applications. Origin Agritech  ( SEED ) +57% reports FY results CN Energy Group  ( CNEY ) +41% . Energy Focus  ( EF...